| scholarly article | Q13442814 |
| meta-analysis | Q815382 |
| P356 | DOI | 10.1177/0333102416686347 |
| P698 | PubMed publication ID | 28058944 |
| P2093 | author name string | C Costa | |
| P Calabresi | |||
| P Sarchielli | |||
| L M Cupini | |||
| P Prontera | |||
| C Bedetti | |||
| S Caproni | |||
| P2860 | cites work | Haploinsufficiency of ATP1A2 encoding the Na+/K+ pump alpha2 subunit associated with familial hemiplegic migraine type 2 | Q24293004 |
| Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860537 | ||
| CACNA1A gene de novo mutation causing hemiplegic migraine, coma, and cerebellar atrophy | Q28142853 | ||
| Novel mutations in the Na+, K+-ATPase pump gene ATP1A2 associated with familial hemiplegic migraine and benign familial infantile convulsions | Q28204791 | ||
| The clinical spectrum of familial hemiplegic migraine associated with mutations in a neuronal calcium channel | Q28204946 | ||
| Specific kinetic alterations of human CaV2.1 calcium channels produced by mutation S218L causing familial hemiplegic migraine and delayed cerebral edema and coma after minor head trauma | Q28237739 | ||
| Variability of familial hemiplegic migraine with novel A1A2 Na+/K+-ATPase variants | Q28263111 | ||
| Alternating hemiplegia of childhood or familial hemiplegic migraine? A novel ATP1A2 mutation | Q28264590 | ||
| Mutation in the neuronal voltage-gated sodium channel SCN1A in familial hemiplegic migraine | Q28264653 | ||
| A G301R Na+/K+ -ATPase mutation causes familial hemiplegic migraine type 2 with cerebellar signs | Q28285675 | ||
| Suppression of cortical spreading depression in migraine prophylaxis | Q28294907 | ||
| Familial hemiplegic migraine and episodic ataxia type-2 are caused by mutations in the Ca2+ channel gene CACNL1A4 | Q28295213 | ||
| Migraine preventive drugs differentially affect cortical spreading depression in rat | Q28296744 | ||
| Two de novo mutations in the Na,K-ATPase gene ATP1A2 associated with pure familial hemiplegic migraine | Q28302086 | ||
| Familial hemiplegic migraine | Q33280531 | ||
| Early seizures and cerebral oedema after trivial head trauma associated with the CACNA1A S218L mutation | Q33466646 | ||
| CaV2.1 channelopathies | Q33537218 | ||
| Antiepileptics in migraine prophylaxis: an updated Cochrane review. | Q34433318 | ||
| Antiepileptic drugs as a possible neuroprotective strategy in brain ischemia | Q35143881 | ||
| Lamotrigine reduces migraine aura and migraine attacks in patients with migraine with aura | Q35485546 | ||
| Evaluation of Presumably Disease Causing SCN1A Variants in a Cohort of Common Epilepsy Syndromes | Q35962539 | ||
| Prolonged hemiplegic episodes in children due to mutations in ATP1A2. | Q36227369 | ||
| Antiepileptic drugs in migraine: from clinical aspects to cellular mechanisms | Q36751286 | ||
| Early-onset familial hemiplegic migraine due to a novel SCN1A mutation | Q37408962 | ||
| Elicited repetitive daily blindness: a new phenotype associated with hemiplegic migraine and SCN1A mutations. | Q37427159 | ||
| The FHM1 mutation S218L: a severe clinical phenotype? A case report and review of the literature | Q37480021 | ||
| Pathophysiological basis of migraine prophylaxis | Q37572061 | ||
| Divergent effects of the T1174S SCN1A mutation associated with seizures and hemiplegic migraine | Q38080592 | ||
| Possible effect of corticoids on hemiplegic attacks in severe hemiplegic migraine | Q40241998 | ||
| Recurrent stroke due to a novel voltage sensor mutation in Cav2.1 responds to verapamil | Q40339838 | ||
| Multimodal neuroimaging in a child with sporadic hemiplegic migraine: a contribution to understanding pathogenesis | Q40340188 | ||
| Methods for quantification of pore-voltage sensor interaction in Ca(V)1.2. | Q41891282 | ||
| Severe and progressive neurotransmitter release aberrations in familial hemiplegic migraine type 1 Cacna1a S218L knock-in mice | Q42970206 | ||
| Sporadic hemiplegic migraine and epilepsy associated with CACNA1A gene mutation | Q43195369 | ||
| Coactivation of GABA(A) and GABA(B) receptor results in neuroprotection during in vitro ischemia | Q44730698 | ||
| Two novel SCN1A mutations identified in families with familial hemiplegic migraine | Q45047442 | ||
| Antiepileptic drugs on calcium currents recorded from cortical and PAG neurons: therapeutic implications for migraine | Q46389732 | ||
| Topiramate-associated worsening symptoms in a patient with familial hemiplegic migraine | Q46500307 | ||
| Severe attacks of familial hemiplegic migraine, childhood epilepsy and ATP1A2 mutation | Q46580212 | ||
| A novel ATP1A2 gene mutation in familial hemiplegic migraine and epilepsy | Q46665221 | ||
| Electroencephalographic changes and seizures in familial hemiplegic migraine patients with the CACNA1A gene S218L mutation | Q46722961 | ||
| The novel p.L1649Q mutation in the SCN1A epilepsy gene is associated with familial hemiplegic migraine: genetic and functional studies. Mutation in brief #957. Online | Q48223071 | ||
| High cortical spreading depression susceptibility and migraine-associated symptoms in Ca(v)2.1 S218L mice | Q48291984 | ||
| Penetrating ballistic-like brain injury in the rat: differential time courses of hemorrhage, cell death, inflammation, and remote degeneration | Q48330569 | ||
| Sporadic hemiplegic migraine and delayed cerebral oedema after minor head trauma: a novel de novo CACNA1A gene mutation | Q48439782 | ||
| Multiple mechanisms underlying the neuroprotective effects of antiepileptic drugs against in vitro ischemia | Q48598679 | ||
| Functional characterization of a novel C-terminal ATP1A2 mutation causing hemiplegic migraine and epilepsy. | Q48621714 | ||
| Hemiconvulsion-hemiplegia-epilepsy syndrome associated with CACNA1A S218L mutation | Q48809798 | ||
| Clinical spectrum in three families with familial hemiplegic migraine type 2 including a novel mutation in the ATP1A2 gene. | Q50687547 | ||
| A wide clinical phenotype spectrum in patients with ATP1A2 mutations. | Q50717674 | ||
| First mutation in the voltage-gated Nav1.1 subunit gene SCN1A with co-occurring familial hemiplegic migraine and epilepsy. | Q51819010 | ||
| A novel de novo nonsense mutation in ATP1A2 associated with sporadic hemiplegic migraine and epileptic seizures. | Q51888180 | ||
| De novo mutations in ATP1A2 and CACNA1A are frequent in early-onset sporadic hemiplegic migraine | Q57811687 | ||
| Familial hemiplegic migraine due to L263V SCN1A mutation: Discordance for epilepsy between two kindreds from Douro Valley | Q57949541 | ||
| CACNA1A Mutation Linking Hemiplegic Migraine and Alternating Hemiplegia of Childhood | Q57956175 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | migraine | Q133823 |
| P304 | page(s) | 333102416686347 | |
| P577 | publication date | 2017-01-01 | |
| P1433 | published in | Cephalalgia | Q5063251 |
| P1476 | title | Epilepsy in hemiplegic migraine: Genetic mutations and clinical implications |
| Q38723250 | A SINE Insertion in ATP1B2 in Belgian Shepherd Dogs Affected by Spongy Degeneration with Cerebellar Ataxia (SDCA2). |
| Q92442251 | Advance in genetics of migraine |
| Q92942241 | Advances in genetics of migraine |
| Q48176878 | Brain atrophy following hemiplegic migraine attacks |
| Q64266150 | Genotype-structure-phenotype relationships diverge in paralogs , , and |
| Q47823990 | HMGB1 mediates microglia activation via the TLR4/NF-κB pathway in coriaria lactone induced epilepsy. |
| Q40095166 | Headache and Epilepsy |
| Q92559438 | The epidemiology of headaches among patients with epilepsy: a systematic review and meta-analysis |
Search more.